Summit Therapeutics Inc. (SMMT) NASDAQ
$4.46 (0.06) (-1.22%)
Market Cap: $3.17B
As of 05/17/24 12:43 PM EDT. Market open.
Summit Therapeutics Inc. (SMMT)
NASDAQ
$4.46
(0.06) (-1.22%)
Market Cap: $3.17B
As of 05/17/24 12:43 PM EDT. Market open.
Add to Portfolio
summit is a uk company focused on the discovery and development of novel drug candidates to treat areas of high unmet medical need. our strategy focuses on two therapy areas: duchenne muscular dystrophy, a fatal genetic muscle wasting disease and the infectious disease caused by the bacteria c. ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Full Time Employees
98
Address
.
PRICE CHART FOR SUMMIT THERAPEUTICS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$4.51
Previous Close
$4.51
Days Range
$4.42 - $4.63
52 week range
$1.50 - $5.39
Volume
429,066
Avg. Volume (30 days)
2,066,323
Market Cap
$3.17B
Dividend Yield
-
P/E
(5.30)
Shares Outstanding
701,979,596
Open
$4.51
Previous Close
$4.51
Days Range
$4.42 - $4.63
52 week range
$1.50 - $5.39
Volume
429,066
Avg. Volume (30 days)
2,066,323
Market Cap
$3.17B
Dividend Yield
-
P/E
(5.30)
Shares Outstanding
701,979,596
FINANCIAL STATEMENTS FOR SUMMIT THERAPEUTICS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR SUMMIT THERAPEUTICS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Zanganeh Mahkam | Chief Executive Officer | Mar 27, 2024 | Buy | $3.71 | 20,000 | 74,200 | 50,000 | Mar 27, 2024, 08:28 PM |
| Zanganeh Mahkam | Chief Executive Officer | Mar 26, 2024 | Buy | $3.75 | 30,000 | 112,500 | 30,000 | Mar 27, 2024, 08:28 PM |
| Zanganeh Mahkam | Chief Executive Officer | Mar 27, 2024 | Buy | $3.72 | 34,321 | 127,674 | 24,923,800 | Mar 27, 2024, 08:28 PM |
| Zanganeh Mahkam | Chief Executive Officer | Mar 27, 2024 | Buy | $3.72 | 26,000 | 96,720 | 520,814 | Mar 27, 2024, 08:28 PM |
| Dhingra Ankur | Chief Financial Officer | Mar 26, 2024 | Buy | $3.75 | 100,000 | 375,000 | 354,958 | Mar 27, 2024, 08:27 PM |
| Zanganeh Mahkam | Chief Executive Officer | Dec 12, 2023 | Buy | $2.07 | 5,000 | 10,350 | 494,814 | Dec 13, 2023, 05:11 PM |
| Zanganeh Mahkam | Chief Executive Officer | Dec 11, 2023 | Option Exercise | $1.58 | 315,681 | 498,776 | 24,889,479 | Dec 13, 2023, 05:11 PM |
| Zanganeh Mahkam | Chief Executive Officer | Dec 11, 2023 | Option Exercise | $1.44 | 489,814 | 705,332 | 489,814 | Dec 13, 2023, 05:11 PM |
| Dhingra Ankur | Chief Financial Officer | Dec 13, 2023 | Buy | $2.17 | 20,400 | 44,254 | 254,958 | Dec 13, 2023, 04:49 PM |
| Soni Manmeet Singh | Chief Operating Officer | Oct 13, 2023 | Buy | $1.68 | 2,976,190 | 4,999,999 | 2,976,190 | Oct 16, 2023, 04:06 PM |
| Zanganeh Mahkam | Co-CEO & President | Mar 08, 2023 | Buy | $1.05 | 16,778,415 | 17,617,335 | 24,573,798 | Mar 13, 2023, 06:27 PM |
| Zanganeh Mahkam | Co-CEO & President | Mar 08, 2023 | Buy | $1.05 | 6,748,629 | 7,086,060 | 9,884,095 | Mar 13, 2023, 06:27 PM |
| Zanganeh Mahkam | Co-Chief Executive Officer | Mar 08, 2023 | Buy | $1.05 | 6,748,629 | 7,086,060 | 9,884,095 | Mar 08, 2023, 09:31 PM |
| Zanganeh Mahkam | Co-Chief Executive Officer | Mar 08, 2023 | Buy | $1.05 | 804,672 | 844,906 | 1,178,529 | Mar 08, 2023, 09:31 PM |
| Zanganeh Mahkam | Co-Chief Executive Officer | Mar 08, 2023 | Buy | $1.05 | 15,973,743 | 16,772,429 | 23,395,269 | Mar 08, 2023, 09:31 PM |
| Dhingra Ankur | Chief Financial Officer | Mar 07, 2023 | Buy | $1.05 | 196,362 | 206,180 | 234,558 | Mar 08, 2023, 05:24 PM |
| Dhingra Ankur | Chief Financial Officer | Aug 16, 2022 | Buy | $0.97 | 24,658 | 23,918 | 38,196 | Mar 08, 2023, 04:58 PM |
| Dhingra Ankur | Chief Financial Officer | Aug 16, 2022 | Buy | $0.97 | 13,027 | 12,636 | 39,527 | Mar 08, 2023, 04:58 PM |
| DUGGAN ROBERT W | Chief Executive Officer | Mar 06, 2023 | Buy | $1.05 | 376,489,880 | 395,314,356 | 552,354,161 | Mar 08, 2023, 04:12 PM |
| DUGGAN ROBERT W | Chief Executive Officer | Aug 16, 2022 | Buy | $0.97 | 94,849,203 | 92,003,730 | 162,532,792 | Aug 18, 2022, 04:38 PM |
| Zanganeh Maky | Co-CEO & President | Aug 16, 2022 | Buy | $0.97 | 1,030,925 | 999,997 | 3,135,466 | Aug 18, 2022, 04:36 PM |
| Zanganeh Maky | Co-CEO & President | Aug 16, 2022 | Buy | $0.97 | 4,593,777 | 4,455,964 | 7,061,557 | Aug 18, 2022, 04:36 PM |
| Zanganeh Maky | Co-CEO & President | Aug 16, 2022 | Buy | $0.97 | 184,430 | 178,897 | 359,969 | Aug 18, 2022, 04:36 PM |
| Dhingra Ankur | Chief Financial Officer | Aug 16, 2022 | Buy | $0.97 | 24,658 | 23,918 | 38,196 | Aug 17, 2022, 04:49 PM |
| Dhingra Ankur | Chief Financial Officer | Aug 16, 2022 | Buy | $0.97 | 11,557 | 11,210 | 38,057 | Aug 17, 2022, 04:49 PM |
| DUGGAN ROBERT W | Chief Executive Officer | May 12, 2021 | Buy | $5.24 | 11,365,921 | 59,557,423 | 67,662,454 | May 14, 2021, 04:39 PM |
| Powell David Jonathan | Chief Scientific Officer | Nov 30, 2020 | Option Exercise | $1.79 | 13,713 | 24,546 | 13,713 | Dec 01, 2020, 07:45 PM |
| Powell David Jonathan | Chief Scientific Officer | Nov 27, 2020 | Option Exercise | $1.86 | 29,569 | 55,089 | 29,569 | Dec 01, 2020, 07:45 PM |
| Powell David Jonathan | Chief Scientific Officer | Nov 30, 2020 | Sale | $4.44 | 13,713 | 60,886 | 0 | Dec 01, 2020, 07:45 PM |
| Powell David Jonathan | Chief Scientific Officer | Nov 27, 2020 | Sale | $4.39 | 29,569 | 129,808 | 0 | Dec 01, 2020, 07:45 PM |
| Powell David Jonathan | Chief Scientific Officer | Nov 25, 2020 | Option Exercise | $1.92 | 12,070 | 23,174 | 12,070 | Nov 25, 2020, 07:51 PM |
| Powell David Jonathan | Chief Scientific Officer | Nov 24, 2020 | Option Exercise | $1.92 | 11,374 | 21,838 | 11,374 | Nov 25, 2020, 07:51 PM |
| Powell David Jonathan | Chief Scientific Officer | Nov 23, 2020 | Option Exercise | $1.92 | 6,987 | 13,415 | 6,987 | Nov 25, 2020, 07:51 PM |
| Powell David Jonathan | Chief Scientific Officer | Nov 25, 2020 | Sale | $4.32 | 12,070 | 52,142 | 0 | Nov 25, 2020, 07:51 PM |
| Powell David Jonathan | Chief Scientific Officer | Nov 24, 2020 | Sale | $4.21 | 11,374 | 47,885 | 0 | Nov 25, 2020, 07:51 PM |
| Powell David Jonathan | Chief Scientific Officer | Nov 23, 2020 | Sale | $4.40 | 6,987 | 30,743 | 0 | Nov 25, 2020, 07:51 PM |
| DUGGAN ROBERT W | Chief Executive Officer | Nov 06, 2020 | Buy | $3.34 | 14,071,856 | 46,999,998 | 56,296,533 | Nov 10, 2020, 04:25 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Zanganeh Mahkam | Chief Executive Officer | 03/27/2024 | 74,200 |
| Zanganeh Mahkam | Chief Executive Officer | 03/26/2024 | 112,500 |
| Zanganeh Mahkam | Chief Executive Officer | 03/27/2024 | 127,674 |
| Zanganeh Mahkam | Chief Executive Officer | 03/27/2024 | 96,720 |
| Dhingra Ankur | Chief Financial Officer | 03/26/2024 | 375,000 |
| Zanganeh Mahkam | Chief Executive Officer | 12/12/2023 | 10,350 |
| Zanganeh Mahkam | Chief Executive Officer | 12/11/2023 | 498,776 |
| Zanganeh Mahkam | Chief Executive Officer | 12/11/2023 | 705,332 |
| Dhingra Ankur | Chief Financial Officer | 12/13/2023 | 44,254 |
| Soni Manmeet Singh | Chief Operating Officer | 10/13/2023 | 4,999,999 |
| Zanganeh Mahkam | Co-CEO & President | 03/08/2023 | 17,617,335 |
| Zanganeh Mahkam | Co-CEO & President | 03/08/2023 | 7,086,060 |
| Zanganeh Mahkam | Co-Chief Executive Officer | 03/08/2023 | 7,086,060 |
| Zanganeh Mahkam | Co-Chief Executive Officer | 03/08/2023 | 844,906 |
| Zanganeh Mahkam | Co-Chief Executive Officer | 03/08/2023 | 16,772,429 |
| Dhingra Ankur | Chief Financial Officer | 03/07/2023 | 206,180 |
| Dhingra Ankur | Chief Financial Officer | 08/16/2022 | 23,918 |
| Dhingra Ankur | Chief Financial Officer | 08/16/2022 | 12,636 |
| DUGGAN ROBERT W | Chief Executive Officer | 03/06/2023 | 395,314,356 |
| DUGGAN ROBERT W | Chief Executive Officer | 08/16/2022 | 92,003,730 |
| Zanganeh Maky | Co-CEO & President | 08/16/2022 | 999,997 |
| Zanganeh Maky | Co-CEO & President | 08/16/2022 | 4,455,964 |
| Zanganeh Maky | Co-CEO & President | 08/16/2022 | 178,897 |
| Dhingra Ankur | Chief Financial Officer | 08/16/2022 | 23,918 |
| Dhingra Ankur | Chief Financial Officer | 08/16/2022 | 11,210 |
| DUGGAN ROBERT W | Chief Executive Officer | 05/12/2021 | 59,557,423 |
| Powell David Jonathan | Chief Scientific Officer | 11/30/2020 | 24,546 |
| Powell David Jonathan | Chief Scientific Officer | 11/27/2020 | 55,089 |
| Powell David Jonathan | Chief Scientific Officer | 11/30/2020 | 60,886 |
| Powell David Jonathan | Chief Scientific Officer | 11/27/2020 | 129,808 |
| Powell David Jonathan | Chief Scientific Officer | 11/25/2020 | 23,174 |
| Powell David Jonathan | Chief Scientific Officer | 11/24/2020 | 21,838 |
| Powell David Jonathan | Chief Scientific Officer | 11/23/2020 | 13,415 |
| Powell David Jonathan | Chief Scientific Officer | 11/25/2020 | 52,142 |
| Powell David Jonathan | Chief Scientific Officer | 11/24/2020 | 47,885 |
| Powell David Jonathan | Chief Scientific Officer | 11/23/2020 | 30,743 |
| DUGGAN ROBERT W | Chief Executive Officer | 11/06/2020 | 46,999,998 |
Load More Insider Transactions
FUNDS WITH A POSITION IN SUMMIT THERAPEUTICS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 9,823,341 | 0.00095% | 0.66% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 3,152,390 | 0.00121% | 2.16% | Other |
| ALPS ADVISORS INC | 494,924 | 0.01% | -7.04% | Other |
| ALPINE GLOBAL MANAGEMENT, LLC | 35,000 | 0.04% | 16.67% | Event Driven |
CHANGE IN SHARES OUTSTANDING FOR SUMMIT THERAPEUTICS INC
STOCK BUYBACKS FOR SUMMIT THERAPEUTICS INC
Period of Report: 03/31/2024
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
12/31/2023
0.04%
1Q
09/30/2023
0.58%
2Q
06/30/2023
0.59%
3Q
BUYBACK ANNOUNCEMENT(S) FOR SUMMIT THERAPEUTICS INC
LOADING...